Concepedia
Statistics
Publications
15
Citations
924
H-Index
14
Active since
1995
Affiliations
New Frontier(Current)
South College
Bristol-Myers Squibb (United States)
GlaxoSmithKline (United States)
Chet Kwon is an author at New Frontier specializing in medicinal chemistry, pharmacology, and drug discovery.
Publications per year
1995–2013
Identification of Novel Inhibitors of the Transforming Growth Factor β1 (TGF-β1) Type 1 Receptor (ALK5)
James F. Callahan, Joelle L. Burgess, James A. Fornwald et al. · Journal of Medicinal Chemistry · 2002 · 309 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +11
Discovery of Orally Active Nonpeptide Vitronectin Receptor Antagonists Based on a 2-Benzazepine Gly-Asp Mimetic
William H. Miller, Doreen Alberts, Pradip K. Bhatnagar et al. · Journal of Medicinal Chemistry · 1999 · 117 citations · Full text
Medicine, Medicinal Chemistry, Pharmacology +7
Discovery of Potent Nonpeptide Vitronectin Receptor (α<sub>V</sub>β<sub>3</sub>) Antagonists
Richard M. Keenan, William H. Miller, Chet Kwon et al. · Journal of Medicinal Chemistry · 1997 · 114 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +10
Potent, Selective, Orally Active 3-Oxo-1,4-benzodiazepine GPIIb/IIIa Integrin Antagonists
James M. Samanen, Fadia E. Ali, Linda S. Barton et al. · Journal of Medicinal Chemistry · 1996 · 72 citations · Full text
Medicine, Medicinal Chemistry, Pharmacology +8
Combinatorial chemistry. Use of an intramolecular ruthenium catalyzed olefin/alkyne metathesis reaction in tandem with a Diels-Alder cycloaddition reaction to construct functionalized hexahydroisoindoles
Dirk A. Heerding, Dennis T. Takata, Chet Kwon et al. · Tetrahedron Letters · 1998 · 51 citations
Natural Sciences, Chemistry, Catalysis +16
1–5 of 15